chap 2: Basic principals Flashcards
- A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to prescribing because:
- Distribution of drugs to target tissue may be affected.
- The solubility of the drug will not match the site of absorption.
- There will be less free drug available to generate an effect.
- Drugs bound to albumin are readily excreted by the kidneys.
- Distribution of drugs to target tissue may be affected.
The route of excretion of a volatile drug will likely be the:
- Kidneys
- Lungs
- Bile and feces
- Skin
- Lungs
Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage reservoir of the drug. Storage reservoirs:
- Assure that the drug will reach its intended target tissue
- Are the reason for giving loading doses
- Increase the length of time a drug is available and active
- Are most common in collagen tissues
- Increase the length of time a drug is available and active
- The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
- Propensity to go to the target receptor
- Biological half-life
- Pharmacodynamics
- Safety and side effects
- Biological half-life
Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the prescription. This is considered a loading dose. A loading dose:
- Rapidly achieves drug levels in the therapeutic range
- Requires four- to five-half-lives to attain
- Is influenced by renal function
- Is directly related to the drug circulating to the target tissues
- Rapidly achieves drug levels in the therapeutic range
The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the:
- Minimum adverse effect level
- Peak of action
- Onset of action
- Therapeutic range
- Onset of action
Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
- When the drug has a wide therapeutic range
- When the drug will be administered for a short time only
- When there is a high correlation between the dose and saturation of receptor sites
- To determine if a drug is in the therapeutic range
- To determine if a drug is in the therapeutic range
A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration. This means that the:
- Concentration will produce therapeutic effects
- Concentration will produce an adverse response
- Time between doses must be shortened
- Duration of action of the drug is too long
- Concentration will produce an adverse response
Drugs that are receptor agonists may demonstrate what property?
- Irreversible binding to the drug receptor site
- Upregulation with chronic use
- Desensitization or downregulation with continuous use
- Inverse relationship between drug concentration and drug action
- Desensitization or downregulation with continuous use
Drugs that are receptor antagonists, such as beta blockers, may cause:
- Downregulation of the drug receptor
- An exaggerated response if abruptly discontinued
- Partial blockade of the effects of agonist drugs
- An exaggerated response to competitive drug agonists
- An exaggerated response if abruptly discontinued
Factors that affect gastric drug absorption include:
- Liver enzyme activity
- Protein-binding properties of the drug molecule
- Lipid solubility of the drug
- Ability to swallow
- Lipid solubility of the drug
Drugs administered via IV:
- Need to be lipid soluble in order to be easily absorbed
- Begin distribution into the body immediately
- Are easily absorbed if they are nonionized
- May use pinocytosis to be absorbed
- Begin distribution into the body immediately
When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
- The sum of the effects of each drug individually
- Greater than the sum of the effects of each drug individually
- Less than the effect of each drug individually
- Not predictable, as it varies with each individual
- Greater than the sum of the effects of each drug individually
- Which of the following statements about bioavailability is true?
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained-release mechanisms.
- All brands of a drug have the same bioavailability.
- Drugs that are administered more than once a day have greater bioavailability than drugs given once daily.
- Combining an active drug with an inert substance does not affect bioavailability.
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained-release mechanisms.
Which of the following statements about the major distribution barriers (blood-brain or fetal-placental) is true?
- Water soluble and ionized drugs cross these barriers rapidly.
- The blood-brain barrier slows the entry of many drugs into and from brain cells.
- The fetal-placental barrier protects the fetus from drugs taken by the mother.
- Lipid-soluble drugs do not pass these barriers and are safe for pregnant women.
- The blood-brain barrier slows the entry of many drugs into and from brain cells